ANTI-SMOKING MEDICATION SHOWS PROMISE FOR TREATING ALCOHOL DEPENDENCE

NIH RESEARCHERS SEEK TO EXPAND TREATMENT OPTIONS

A smoking-cessation medication may be a viable option for the treatment of alcohol dependence, according to a study by NIH scientists. The study found that varenicline (marketed under the name Chantix), approved in 2006 to help people stop smoking, significantly reduced alcohol consumption and craving among people who are alcohol-dependent. The findings were published online in the Journal of Addiction Medicine.

Press Release: http://www.nih.gov/news/health/jun2013/niaaa-03.htm

The Quitting Smoking Channel

Pfizer Inc. recently launched a new branded consumer YouTube channel for CHANTIX (varenicline) tablets called The Quitting Smoking Channel.

 

The YouTube channel will initially house 13 videos that highlight various topics including tools to quitting smoking, the importance of smoking cessation, treatment options for smoking cessation, the important of support in quitting smoking, all from the point of view of a physician, tobacco treatment specialist, successful CHANTIX quitter, and potential CHANTIX quitter.

 

This channel is meant to encourage smokers to think about quitting smoking and to talk to their doctors about CHANTIX. Pfizer hopes that the channel will inspire smokers to think about making a new quit attempt, think differently about the important role of a plan to quit smoking that includes support and, ultimately, to talk to their health care professionals to discuss options.